Pacer Advisors, Inc. Agios Pharmaceuticals, Inc. Transaction History

Pacer Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$27.55 - $48.83 $16,364 - $29,005	-594 Reduced 57.61%	437 $18,000
Q1 2024 May 10, 2024	BUY	$21.32 - $34.81 $21,980 - $35,889	1,031 New	1,031 $30,000
Q2 2021 Jul 21, 2021	SELL	$52.06 - $61.27 $78,298 - $92,150	-1,504 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$44.23 - $57.5 $107,036 - $139,150	-2,420 Reduced 61.67%	1,504 $78,000
Q4 2020 Jan 20, 2021	BUY	$33.21 - $46.54 $56,290 - $78,885	1,695 Added 76.04%	3,924 $170,000
Q3 2020 Oct 19, 2020	BUY	$33.87 - $55.93 $75,496 - $124,667	2,229 New	2,229 $78,000
Q4 2018 Feb 13, 2019	SELL	$42.73 - $76.53 $142,205 - $254,691	-3,328 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $238,517 - $306,009	3,328 New	3,328 $257,000
Q1 2018 May 14, 2018	SELL	$59.83 - $86.53 $64,317 - $93,019	-1,075 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $56,029 - $77,754	1,075	1,075 $61,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.